Healio: FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas Tirbanibulin ointment 1% shows good safety and tolerability in the treatment of actinic keratosis (AK) in fields of up to 100 cm 2 on the face and scalp. The most common local effects of treatment ... Nasdaq: Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp Please provide your email address to receive an email when new articles are posted on .

Understanding the Context

The FDA has approved the expanded use area of Klisyri to up to 100 cm 2 on the face and scalp for the treatment ... Healio: FDA approves increase of Ameluz dosing from one to three tubes for actinic keratosis FDA approves increase of Ameluz dosing from one to three tubes for actinic keratosis